Rrecent studies have highlighted the connection between ID4 induction and downregulation of BRCA1 in TNBCs [53] as well as with p53 mutation in estrogen receptor negative (ER-) breast tumours [54] that might contribute to chemoresistance of p53 mutant breast tumours [55]. Here, TP53 is linked to breast neoplasm.